Atreca, Inc. Consolidated Net Income/Loss

Consolidated Net Income/Loss of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending September 30, 2022 was $-23.1 Million (a -17.28% decrease compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss decreased by -21.88%
  • Annual Consolidated Net Income/Loss for 2021 was $-109 Million (a 26.63% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2020 was $-86.3 Million (a 27.93% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2019 was $-67.5 Million (a 77.86% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending September 30, 2022 was $-105 Million (a -3.92% decrease compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss decreased by -3.66% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-105 Million $-110 Million $-108 Million $-109 Million
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of Atreca, Inc.

Most recent Consolidated Net Income/Lossof BCEL including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of Atreca, Inc.

Atreca, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-23.06 $-27.88 $-24.88
2021 $-29.52 $-27.36 $-26.68 $-25.78 $-109.32
2020 $-23.01 $-22.93 $-19.98 $-20.42 $-86.33
2019 $-20.11 $-15.87 $-17.92 $-13.58 $-67.48
2018 $-9.63 $-8.67 $-37.94
2017 $-27.53

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology